Order Article Reprints

Diamantopoulos PT, Kontandreopoulou C-N, Stafylidis C, Vlachopoulou D, Smilakou S, Patsialos I, Syriopoulou S, Gkikas A, Athanasopoulos EN, Vogiatzakis A, et al. Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma. Vaccines. 2024; 12(11):1216. https://doi.org/10.3390/vaccines12111216

Diamantopoulos, Panagiotis T., Christina-Nefeli Kontandreopoulou, Christos Stafylidis, Dimitra Vlachopoulou, Stavroula Smilakou, Iraklis Patsialos, Stavroula Syriopoulou, Alexandros Gkikas, Eleftherios N. Athanasopoulos, Anastasios Vogiatzakis, and et al. 2024. "Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma" Vaccines 12, no. 11: 1216. https://doi.org/10.3390/vaccines12111216

Diamantopoulos, P. T., Kontandreopoulou, C.-N., Stafylidis, C., Vlachopoulou, D., Smilakou, S., Patsialos, I., Syriopoulou, S., Gkikas, A., Athanasopoulos, E. N., Vogiatzakis, A., Panousi, E., Kyriakakis, G., Anastasopoulou, A., Mantzourani, M., & Labropoulou, V. (2024). Immunogenicity and Safety of the Recombinant Adjuvanted Herpes Zoster Vaccine in Patients with Chronic Lymphocytic Leukemia and Multiple Myeloma. Vaccines, 12(11), 1216. https://doi.org/10.3390/vaccines12111216